Peter Carmeliet: Angiogenesis revisited: role and (therapeutic) implications of endothelial metabolism
Laboratory of Angiogenesis and Vascular Metabolism, VIB-KU Leuven Center for Cancer Biology, Department of Oncology KU Leuven, BE
Dr. Peter Carmeliet is head of the Laboratory of Angiogenesis and Vascular Metabolism and former director of the VIB-Vesalius Research Center, now called VIB-KU Leuven Center for Cancer Biology. He graduated as Doctor in Medicine in 1984 at the University of Leuven in Belgium, completed his PhD in 1989, and performed a postdoctoral training at the Whitehead Institute, MIT in Cambridge USA. After his return to Leuven in 1992, Dr. Carmeliet started his own research group with a focus on how blood vessels grow (angiogenesis) in health and disease.
Dr. Carmeliet has published over 670 articles (>78.701 citations, h-index: 133). His achievements have been recognized by several honors and awards.
The Carmeliet lab is currently studying how endothelial cells change their metabolism during vascular branching and exploring the therapeutic potential of targeting endothelial metabolism for anti-angiogenic strategies. The role of several key metabolic targets in endothelial cell biology and angiogenesis in vivo is under investigation.
Peter Carmeliet has won various awards, including the Francqui Prize in Biological and Medical Sciences (2002) Interbrew-Baillet Latour Health Prize (2005), the Ernst Jung Prize in Medicine (2010) and the Heineken Prize for Medicine (2018). In 2015 he was granted the Noble title of ‘Baron’ by King Filip of Belgium. He was elected a foreign member of the Royal Netherlands Academy of Arts and Sciences in 2017.